Skip to main content
Coreo AG logo

Coreo AG — Investor Relations & Filings

Ticker · CORE ISIN · DE000A40KYB8 LEI · 391200FQ2JQTU4IUY679 F Real estate activities
Open in API
Filings indexed 417 across all filing types
Latest filing 2009-03-26 Regulatory Filings
Country DE Germany
Listing F CORE

About Coreo AG

https://coreo.de/en/

Coreo AG is a real estate investment company focused on the acquisition, development, and management of residential and commercial properties. The company's strategy centers on value-add opportunities, targeting properties with significant potential for appreciation. Coreo AG employs an active 'manage to core' approach to sustainably increase the value of its assets, with the goal of building and expanding an efficiently managed, high-yield real estate portfolio. Investment focus is primarily on residential properties, preferably in medium-sized centers, with individual investment volumes typically ranging from 5 to 20 million euros. The company's portfolio comprises a mix of residential, commercial, and combined-use properties.

Recent filings

Filing Released Lang Actions
Nanostart holding Nanosys: Cooperation for anti-counterfeit solutions with multi-billion dollar biotech company Life Technologies
Regulatory Filings Classification · 100% confidence The document is a press release titled 'Nanostart holding Nanosys: Cooperation for anti-counterfeit solutions with multi-billion dollar biotech company Life Technologies'. It announces a cross-licensing agreement regarding intellectual property for quantum dots to combat counterfeiting. This type of announcement, detailing a strategic business development or partnership, does not fit the specific financial reporting categories like 10-K, ER, or IR. It is a general corporate news item. Since it is not a formal regulatory filing (like a 10-K or 8-K equivalent in this context) and deals with business strategy/partnership, the most appropriate general category is 'Regulatory Filings' (RNS) as a fallback for miscellaneous corporate news that isn't explicitly defined elsewhere, although 'LTR' (Legal Proceedings Report) or 'TAR' (M&A Activity) are related to corporate actions, this is a licensing agreement, not a merger or lawsuit. Given the options, RNS serves as the best catch-all for significant, non-standard corporate news releases.
2009-03-26 English
Nanostart AG: Nanostart-Holding NanoGram Corporation and Teijin Limited Enter Technology
Regulatory Filings Classification · 100% confidence The document is a short news release dated March 18, 2009, announcing a technology development agreement between Nanostart-Holding NanoGram Corporation and Teijin Limited. It is transmitted by DGAP, which typically handles regulatory news. The content is a corporate announcement about a business development (a partnership/agreement), not a formal financial report (like 10-K, IR, ER) or a specific shareholder action (like DIV, DVA). Since it is a general corporate news item that doesn't fit the highly specific financial report categories, the most appropriate classification is the general regulatory announcement fallback category, RNS (Regulatory Filings). The document length is short (4655 chars) and it functions as a news update, fitting the general nature of RNS.
2009-03-18 English
Nanostart-Beteiligung MagForce will dieses Jahr Zulassung fur Krebstherapie beantragen
Regulatory Filings Classification · 100% confidence The document is a short corporate news release dated February 11, 2009, announcing that MagForce Nanotechnologies AG (a Nanostart investment) plans to apply for European approval for its Nano-Krebs® therapy this year. It discusses clinical trials, potential market entry, and includes quotes from management and a government minister. The structure (News Details, Corporate, DGAP distribution) strongly suggests a regulatory announcement rather than a full financial report (like 10-K or IR) or a detailed presentation (IP). Since it is a general corporate announcement regarding business progress and regulatory milestones, and it doesn't fit perfectly into specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for official, non-specific corporate news releases distributed via regulatory channels (like DGAP in Germany). Given the length (under 5,000 characters) and the nature of the content (announcing future plans/milestones), RNS is the most appropriate fit among the provided options for a general news update.
2009-02-11 German
Nanostart-held Curiox successfully enters market in Singapore
Regulatory Filings Classification · 100% confidence The document is a press release titled "News Details" from Nanostart AG concerning its portfolio company, Curiox Biosystems, announcing a successful market debut and new customer acquisition in Singapore. It details product usage, management commentary, and company background. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (like IR or AR), falls best under the general category for miscellaneous corporate news or regulatory announcements that don't fit elsewhere. Given the options, it is a general corporate announcement. Since there is no specific category for 'General Corporate News' or 'Press Release', and it is not a formal financial report, it defaults to the most appropriate general regulatory/announcement category, which is RNS (Regulatory Filings/Miscellaneous Announcements). It is too detailed to be a simple Report Publication Announcement (RPA) which usually just points to another document.
2009-01-13 English
Nanostart AG: Nanostart AG fuhrt erfolgreich Kapitalerhohung durch
Share Issue/Capital Change Classification · 98% confidence The document text is a corporate news release dated December 5, 2008, titled "Nanostart AG führt erfolgreich Kapitalerhöhung durch" (Nanostart AG successfully completes capital increase). The content explicitly details the issuance of 360,000 new shares, the use of simplified subscription rights exclusion (§ 186 Abs. 3 Satz 4 AktG), and the strengthening of the capital base. This directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). The document length is short (3026 chars), but it is the primary announcement of the event, not just an announcement of a report, making CAP more specific than RPA or RNS.
2008-12-05 German
Evolved Machines enters into License Agreement with Nanostart holding Nanosys
Regulatory Filings Classification · 100% confidence The document is a short news release dated December 4, 2008, announcing a specific corporate event: Evolved Machines entering into a sublicense agreement with Nanostart holding Nanosys regarding patent portfolios. It is structured like a press release, transmitted by DGAP, and focuses on a specific business development (licensing/IP). This type of announcement, detailing a specific transaction or business update that isn't a standard periodic report (like 10-K, IR, ER) or a management change (MANG), typically falls under general regulatory announcements or miscellaneous corporate news. Since it is not a major financing event (CAP), M&A (TAR), or director dealing (DIRS), the most appropriate general category for a specific, non-standard corporate update transmitted via a news service is Regulatory Filings (RNS), which serves as the fallback for miscellaneous announcements.
2008-12-04 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.